United Health Pr Financials
This page shows United Health Pr (UEEC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
External financing, not internally generated cash, is carrying UEEC as liabilities outrun assets and liquidity thins.
FY2025 operating cash burn remained about-$1.19M , while financing inflows eased to$1.08M . Because FY2024 funding had been higher, cash fell to$65K from$169K , showing outside capital is still essential and now covers the business less completely than a year earlier, a sign of weaker cash replenishment rather than a lower burn rate.
The balance-sheet posture is becoming more imbalanced: total liabilities reached
Near-term liquidity also tightened as the current ratio sank to 0.03x and cash ended FY2025 at
Financial Health Signals
We are recalculating United Health Pr's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Key Financial Metrics
Earnings & Revenue
United Health Pr generated $0 in revenue in fiscal year 2025.
United Health Pr earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Cash & Balance Sheet
United Health Pr held $65K in cash against $0 in long-term debt as of fiscal year 2025.
United Health Pr had 259M shares outstanding in fiscal year 2025. This represents an increase of 2.5% from the prior year.
Margins & Returns
Capital Allocation
United Health Pr invested $270K in research and development in fiscal year 2025. This represents a decrease of 24.2% from the prior year.
UEEC Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | N/A | $0 | $0 | $0 | N/A | $0 | $0 |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $13K | N/A | $25K-68.7% | $81K-30.3% | $116K | N/A | $66K+0.3% | $66K |
| SG&A Expenses | $253K | N/A | $208K+10.9% | $187K | N/A | N/A | $326K-4.0% | $339K |
| Operating Income | -$266K | N/A | -$233K+13.1% | -$268K | N/A | N/A | -$392K+3.3% | -$405K |
| Interest Expense | $48K | N/A | $31K+22.2% | $25K+21.2% | $21K | N/A | $8K0.0% | $8K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$316K | N/A | -$286K+9.4% | -$315K | N/A | N/A | -$304K+29.7% | -$432K |
| EPS (Diluted) | $0.00 | N/A | $0.00 | $0.00+100.0% | $-0.01 | N/A | $0.00 | $0.00 |
UEEC Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $249K-21.4% | $317K+235.8% | $94K+15.7% | $82K-22.0% | $105K-61.3% | $270K+79.2% | $151K+23.8% | $122K |
| Current Assets | $47K-55.2% | $105K+144.4% | $43K+104.3% | $21K-39.8% | $35K-81.7% | $192K+201.0% | $64K+142.2% | $26K |
| Cash & Equivalents | $1K-98.4% | $65K+255.1% | $18K+8067.1% | $225-95.4% | $5K-97.1% | $169K+285.7% | $44K+133.5% | $19K |
| Inventory | N/A | $0 | N/A | N/A | N/A | $0 | $0 | $0 |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $4.4M+5.9% | $4.2M+22.1% | $3.4M+5.6% | $3.3M+9.9% | $3.0M+9.1% | $2.7M+20.0% | $2.3M+6.5% | $2.1M |
| Current Liabilities | $4.2M+6.3% | $3.9M+96.5% | $2.0M+5.3% | $1.9M+5.4% | $1.8M+10.1% | $1.6M-26.6% | $2.2M+6.9% | $2.1M |
| Long-Term Debt | N/A | N/A | $928K+9.4% | $848K | N/A | N/A | N/A | N/A |
| Total Equity | -$4.2M-8.1% | -$3.9M-16.1% | -$3.3M-5.3% | -$3.2M-11.0% | -$2.9M-16.8% | -$2.4M-15.8% | -$2.1M-5.4% | -$2.0M |
| Retained Earnings | -$81.7M-0.4% | -$81.4M-0.7% | -$80.8M-0.4% | -$80.5M-0.4% | -$80.2M-1.9% | -$78.7M-1.0% | -$77.9M-0.4% | -$77.6M |
UEEC Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$84K+84.8% | -$553K-215.8% | -$175K+5.2% | -$185K+32.6% | -$274K-51.0% | -$181K+43.3% | -$320K-11.1% | -$288K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $20K-96.6% | $600K+210.4% | $193K+7.4% | $180K+63.6% | $110K-64.1% | $307K-11.1% | $345K+52.9% | $226K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
UEEC Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -126.9% | N/A | -302.8%+83.7pp | -386.6% | N/A | N/A | -201.6%+153.4pp | -355.0% |
| Current Ratio | 0.01-0.0 | 0.030.0 | 0.02+0.0 | 0.010.0 | 0.02-0.1 | 0.12+0.1 | 0.03+0.0 | 0.01 |
| Debt-to-Equity | -1.06+0.0 | -1.08-0.8 | -0.28-0.0 | -0.27+0.8 | -1.04+0.1 | -1.11-0.0 | -1.07-0.0 | -1.06 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$3.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is United Health Pr's annual revenue?
United Health Pr (UEEC) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
What is United Health Pr's operating cash flow?
United Health Pr (UEEC) generated -$1.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are United Health Pr's total assets?
United Health Pr (UEEC) had $317K in total assets as of fiscal year 2025, including both current and long-term assets.
How much does United Health Pr spend on research and development?
United Health Pr (UEEC) invested $270K in research and development during fiscal year 2025.
What is United Health Pr's current ratio?
United Health Pr (UEEC) had a current ratio of 0.03 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is United Health Pr's debt-to-equity ratio?
United Health Pr (UEEC) had a debt-to-equity ratio of -1.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is United Health Pr's cash runway?
Based on fiscal year 2025 data, United Health Pr (UEEC) had $65K in cash against an annual operating cash burn of $1.2M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is United Health Pr's debt-to-equity ratio negative or unusual?
United Health Pr (UEEC) has negative shareholder equity of -$3.9M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.